Pharmaceutical Manufacturer Gaelic Labs Acquires Athlone Laboratories

Gaelic Laboratories, a pharmaceutical manufacturer specializing in Beta-Lactam (penicillin) products, has acquired Athlone Laboratories, a developer and manufacturer of oral dose Beta-Lactams. Both companies are based in Ireland and possess strong reputations within the Beta-Lactam antibiotics sector.

The acquisition is expected to bolster Gaelic Labs’ market position, enhance its manufacturing capabilities, and leverage supply chain efficiencies. The companies state that combining their complementary offerings will enable them to expand their product ranges and drive operational efficiencies. This move aligns with Gaelic Labs’ long-term strategy to establish itself as a leader in the production and distribution of generic Beta-Lactam medicines.

The General Manager of Gaelic Labs indicated that the deal is anticipated to yield significant financial and operational benefits, including cost savings via manufacturing consolidation, revenue growth, and increased regulatory advantages. Athlone is considered a key player in the Beta-Lactam supply chain, providing substantial operational synergies.

Gaelic Labs is committed to retaining the personnel at the Athlone site, including the current management team, to ensure operational continuity and a seamless transition for partners, suppliers, and customers. Athlone’s leadership will report to the General Manager of Gaelic Labs, who will have hierarchical oversight of both entities.

Following the acquisition, Gaelic Labs’ total workforce has more than doubled to approximately 120 people. The company is implementing transition programs to retain Athlone’s expertise. All existing product lines and customer contracts are expected to continue without disruption.

Source: https://www.contractpharma.com/breaking-news/gaelic-laboratories-acquires-athlone-laboratories/